A study of the use of carbamazepine, pregabalin and alpha lipoic acid in patients of diabetic neuropathy

Journal of Diabetes and Metabolic Disorders

Volumn 13, Issue 1, 2014, Pages

  Patel, Niral ^a   Mishra, Vishal ^b   Patel, Prakruti ^c   Dikshit, Ram K ^d  

^a Medwise Pharmaceuticals   (India)

^b GMERS medical colloge ^*  (India)

^c CIVIL HOSPITAL   (India)

^d Preventive and Social Medicine GCS Medical College   (India)

Author keywords

Alpha lipoic acid; Carbamazepine; Diabetic neuropathy; Pregabalin

Indexed keywords

CARBAMAZEPINE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT; PREGABALIN; THIOCTIC ACID;

ADULT; ANALGESIA; ARTICLE; CLINICAL TRIAL; CORRELATION ANALYSIS; DEMOGRAPHY; DIABETES MELLITUS; DIABETIC NEUROPATHY; DIABETIC NEUROPATHY EXAMINATION SCORE; DIABETIC NEUROPATHY SYMPTOM SCORE; DIET RESTRICTION; DRUG EFFICACY; DRUG ERUPTION; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NERVE CONDUCTION; OBSERVATIONAL STUDY; PAIN ASSESSMENT; PAIN SEVERITY; PATIENT COMPLIANCE; POSTPRANDIAL STATE; PRESCRIPTION; PROSPECTIVE STUDY; SCORING SYSTEM; SOMNOLENCE; SYMPTOM; TREATMENT OUTCOME; TREATMENT RESPONSE; VISUAL ANALOG SCALE;

EID: 84906534679     PISSN: None     EISSN: 22516581     Source Type: Journal    
DOI: 10.1186/2251-6581-13-62     Document Type: Article

References (30)

1. Fedele D, Comi G, Coscelli C, Cucinotta D, Feldman EL, Ghirlanda G, Greene DA, Negrin P, Santeusanio F. A multicenter study on the prevalence of diabetic neuropathy in Italy. Italian Diabetic Neuropathy Committee. Diabetes Care 1997, 20(5):836-843. 10.2337/diacare.20.5.836, 9135952.
2. Pirart J. Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973 (3rd and last part). Diabetes Metab 1977, 3:245-256.
3. Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, Malik RA, Maser RE, Sosenko JM, Ziegler D, . American Diabetes Association Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 2005, 28(9):56-62. American Diabetes Association.
4. Vileikyte L, Leventhal H, Gonzalez JS, Peyrot M, Rubin RR, Ulbrecht JS, Garrow A, Waterman C, Cavanagh PR, Boulton AJ. Diabetic peripheral neuropathy and depressive symptoms: the association revisited. Diabetes Care 2005, 28:2378-2383. 10.2337/diacare.28.10.2378, 16186266.
5. American diabetes association. Living with diabetes. High blood pressure (hypertension). Available from: http://www.diabetes.org/living-with-diabetes/complications/high-blood-pressure-hypertension.html.
6. Pop-Busui R, Sima A, Stevens M. Diabetic neuropathy and oxidative stress. Diabetes Metab Res Rev 2006, 22:257-273. 10.1002/dmrr.625, 16506271.
7. Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, Kojima Y, Furuyoshi N, Shichiri M. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 1995, 28:103-117. 10.1016/0168-8227(95)01064-K, 7587918.
8. Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993, 329:977-986. Diabetes Control and Complications Trial Research Group.
9. Huizinga M, Peltier A. Painful diabetic neuropathy: a management-centered review. Clin Diabetes 2007, 25:6-15.
10. Dauphin A, Guillemin F, Virion J, Briançon S. Bias and precision in visual analogue scales: a randomized controlled trial. Am J Epidemiol 1999, 150(10):1117-1127. 10.1093/oxfordjournals.aje.a009937, 10568628.
11. Meijer JW, Smit AJ, Sonderen EV, Groothoff JW, Eisma WH, Links TP. Symptom scoring systems to diagnose distal polyneuropathy in diabetes: the Diabetic Neuropathy Symptom score. Diabet Med 2000, 19(11):962-965.
12. Meijer JW, Sonderen E, Blaauwwiekel EE, Smit AJ, Groothoff JW, Eisma WH, Links TP. Diabetic neuropathy examination: a hierarchical scoring system to diagnose distal polyneuropathy in diabetes. Diabetes Care 2000, 23:750-753. 10.2337/diacare.23.6.750, 10840990.
13. Tesfaye S, Boulton AJ, Dyck PJ, Freeman R, Horowitz M, Kempler P, Lauria G, Malik RA, Spallone V, Vinik A, Bernardi L, Valensi P, . Toronto Diabetic Neuropathy Expert Group Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 2010, 33:2285-2293. 10.2337/dc10-1303, 2945176, 20876709, Toronto Diabetic Neuropathy Expert Group.
14. Dyck PJ, Davies JL, Wilson DM, Service FJ, Melton LJ, O'Brien P. Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort. Diabetes Care 1999, 22(9):1479-1486. 10.2337/diacare.22.9.1479, 10480512.
15. Dutta A, Naorem S, Singh T, Wangjam K. Prevalence of peripheral neuropathy in newly diagnosed type 2 diabetes. Int J Diabetes Dev Ctries 2005, 25:30-33.
16. Pradeepa R, Rema M, Vignesh J, Deepa M, Deepa R, Mohan V. Prevalence and risk factors for diabetic neuropathy in an urban south Indian population: the Chennai Urban Rural Epidemiology Study (CURES-55). Diabet Med 2008, 25:407-412. 10.1111/j.1464-5491.2008.02397.x, 18294224.
17. Janghorbani M, Rezvanian H, Kachooei A, Ghorbani A, Chitsaz A, Izadi F, Amini M. Peripheral neuropathy in type 2 diabetes mellitus in Isfahan, Iran: prevalence and risk factors. Int J Diabetes Metab 2006, 14:126-133.
18. American Diabetes Association Diabetes Care 2002, 25(1):28-32. American Diabetes Association.
19. Lesser H, Sharma U, LaMoreaux L, Poole RM. Pregabalin relieves symptoms of painful diabetic neuropathy. Neurology 2004, 63(11):2104-2110. 10.1212/01.WNL.0000145767.36287.A1, 15596757.
20. Freeman R, Durso-Decruz E, Emir B. Efficacy, safety and tolerability of pregabalin treatment for painful diabetic peripheral neuropathy: findings from seven randomized, controlled trials across a range of doses. Diabetes Care 2008, 31:1448-1454. 10.2337/dc07-2105, 2453685, 18356405.
21. Bodian CA, Freedman G, Hossain S, Eisenkraft JB, Beilin Y. The visual analog scale for pain: clinical significance in postoperative patients. Anesthesiology 2001, 95:1356-1361. 10.1097/00000542-200112000-00013, 11748392.
22. Taylor CP, Angelotti T, Fauman E. Pharmacology and mechanism of action of pregabalin: the calcium channel alpha2-delta (alpha2-delta) subunit as a target for antiepileptic drug discovery. Epilepsy Res 2007, 73:137-150. 10.1016/j.eplepsyres.2006.09.008, 17126531.
23. Dyck PJ. Detection, characterization and staging of polyneuropathy: assessed in diabetics. Muscle Nerve 1988, 11:21-32. 10.1002/mus.880110106, 3277049.
24. Hamandi K, Sander JW. Pregabalin: a new antiepileptic drug for refractory epilepsy. Seizure 2006, 15(2):73-78. 10.1016/j.seizure.2005.11.005, 16413993.
25. Brasier AR. The NF-kappaB regulatory network. Cardiovasc Toxicol 2006, 6:111-130. 10.1385/CT:6:2:111, 17303919.
26. Shay P, Moreau RF, Smith EJ, Hagen TM. Is alpha-lipoic acid a scavenger of reactive oxygen species in vivo? Evidence for its initiation of stress signaling pathways that promote endogenous antioxidant capacity. IUBMB Life 2008, 60:362-367. 10.1002/iub.40, 18409172.
27. Kong X, Lesser EA, Potts FA, Gozani SN. Utilization of nerve conduction studies for the diagnosis of polyneuropathy in patients with diabetes: a retrospective analysis of a large patient series. J Diabetes Sci Technol 2008, 2(2):268-274. 10.1177/193229680800200217, 2771502, 19885354.
28. Arezzo JC, Rosenstock J, LaMoreaux L, Pauer L. Efficacy and safety of pregabalin 600 mg/d for treating painful diabetic peripheral neuropathy: a double-blind placebo-controlled trial. BMC Neurol 2008, 8:33. 10.1186/1471-2377-8-33, 2565674, 18796160.
29. Chakrabarti AK, Samantaray SK. Diabetic peripheral neuropathy: nerve conduction studies before, during and after carbamazepine therapy. Aust NZJ Med 1976, 6:565-568.
30. Han T, Bai J, Liu W, Hu Y. A systematic review and meta-analysis of alpha lipoic acid in the treatment of diabetic peripheral neuropathy. Eur J Endocrinol 2012, 167:465-471. 10.1530/EJE-12-0555, 22837391.